Jazz Pharmaceuticals (JAZZ) PT Raised to $280 at Baird
Tweet
Share
E-mailGet Alerts JAZZ Hot Sheet
Price: $243.66 -0.02%
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 31
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 31
Join SI Premium – FREE
Baird analyst Brian Skorney raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $280.00 (from $252.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Braze Inc (BRZE) PT Raised to $40 at DA Davidson
- Dell (DELL) PT Raised to $635 at JPMorgan on Robust Q2 Results
- Livanova (LIVN) PT Raised to $90 at Piper Sandler
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
